HCC-derived EVs trigger the activation of PI3K/Akt and MAPK signaling pathways and the secretion of active MMP2 and MMP9 matrix metalloproteinases (MMPs) in hepatocytes, which in turn enhance their migratory and invasive ability. The gene discussed is AKT1; the disease is hepatocellular carcinoma.